EXELIXIS INC. - Daily - Technical analysis published on 01/11/2021 (GMT)
- 306
- 0
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Additional analysis
Quotes
The EXELIXIS INC. rating is 24.57 USD. The price registered an increase of +7.67% on the session and was traded between 23.52 USD and 24.60 USD over the period. The price is currently at +4.46% from its lowest and -0.12% from its highest.The Central Gaps scanner detects the formation of a bullish gap marking the strong presence of buyers against sellers at the opening. This formed a quotation gap.
Opening Gap UP
Type : Bullish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
Technical
A technical analysis in Daily of this EXELIXIS INC. chart shows a bullish trend. The signals returned by the moving averages are 78.57% bullish. This bullish trend is reinforced by the strong signals currently being given by short-term moving averages. There is no crossing of moving average by the price or crossing of moving averages between themselves.
In fact, according to the parameters integrated into the Central Analyzer system, 17 technical indicators out of 18 analysed are currently bullish. Caution: the Central Indicators scanner currently detects an excess:
RSI indicator is overbought : over 70
Type : Neutral
Timeframe : Daily
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : Daily
Previous candle closed over Bollinger bands
Type : Neutral
Timeframe : Daily
CCI indicator: bearish divergence
Type : Bearish
Timeframe : Daily
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : Weekly
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : Daily
Ichimoku : price is over the cloud
Type : Bullish
Timeframe : Daily
The Central Patterns scanner, which studies chart patterns, resistances and supports, has identified these signals:
Horizontal resistance is broken
Type : Bullish
Timeframe : Daily
Resistance of channel is broken
Type : Bullish
Timeframe : Daily
No result was found by the Central Candlesticks scanner on Japanese candlesticks.
S3 | S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|---|
ProTrendLines | 20.67 | 21.63 | 22.65 | 24.57 | 24.76 | 25.60 | 27.42 |
Change (%) | -15.87% | -11.97% | -7.81% | - | +0.77% | +4.19% | +11.60% |
Change | -3.90 | -2.94 | -1.92 | - | +0.19 | +1.03 | +2.85 |
Level | Major | Intermediate | Minor | - | Major | Minor | Major |
Attention could also be paid to pivot points to set price objectives:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 21.68 | 22.07 | 22.45 | 22.84 | 23.21 | 23.60 | 23.98 |
Camarilla | 22.61 | 22.68 | 22.75 | 22.82 | 22.89 | 22.96 | 23.03 |
Woodie | 21.67 | 22.07 | 22.44 | 22.83 | 23.20 | 23.60 | 23.97 |
Fibonacci | 22.07 | 22.36 | 22.54 | 22.84 | 23.13 | 23.31 | 23.60 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 17.28 | 18.55 | 20.69 | 21.96 | 24.09 | 25.36 | 27.50 |
Camarilla | 21.88 | 22.20 | 22.51 | 22.82 | 23.13 | 23.44 | 23.76 |
Woodie | 17.71 | 18.77 | 21.12 | 22.17 | 24.52 | 25.58 | 27.93 |
Fibonacci | 18.55 | 19.85 | 20.65 | 21.96 | 23.26 | 24.06 | 25.36 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 16.28 | 17.44 | 18.75 | 19.91 | 21.22 | 22.38 | 23.69 |
Camarilla | 19.39 | 19.62 | 19.84 | 20.07 | 20.30 | 20.52 | 20.75 |
Woodie | 16.37 | 17.48 | 18.84 | 19.95 | 21.31 | 22.42 | 23.78 |
Fibonacci | 17.44 | 18.38 | 18.96 | 19.91 | 20.85 | 21.43 | 22.38 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
RSI (14): | 79.58 | |
MACD (12,26,9): | 0.7500 | |
Directional Movement: | 33.29 | |
AROON (14): | 92.86 | |
DEMA (21): | 21.92 | |
Parabolic SAR (0,02-0,02-0,2): | 20.76 | |
Elder Ray (13): | 2.41 | |
Super Trend (3,10): | 21.61 | |
Zig ZAG (10): | 24.42 | |
VORTEX (21): | 1.2500 | |
Stochastique (14,3,5): | 95.81 | |
TEMA (21): | 22.79 | |
Williams %R (14): | -0.57 | |
Chande Momentum Oscillator (20): | 4.37 | |
Repulse (5,40,3): | 7.2900 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 0.2500 | |
Courbe Coppock: | 19.54 |
MA7: | 21.94 | |
MA20: | 20.86 | |
MA50: | 20.23 | |
MA100: | 21.65 | |
MAexp7: | 22.36 | |
MAexp20: | 21.13 | |
MAexp50: | 20.86 | |
MAexp100: | 21.31 | |
Price / MA7: | +11.99% | |
Price / MA20: | +17.79% | |
Price / MA50: | +21.45% | |
Price / MA100: | +13.49% | |
Price / MAexp7: | +9.88% | |
Price / MAexp20: | +16.28% | |
Price / MAexp50: | +17.79% | |
Price / MAexp100: | +15.30% |
News
Don"t forget to follow the news on EXELIXIS INC.. At the time of publication of this analysis, the latest news was as follows:
- Exelixis Announces Preliminary Fourth Quarter and Full Year 2020 Financial Results, Provides 2021 Financial Guidance, and Outlines Key Priorities and Anticipated Milestones For 2021
- Exelixis to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021
- Exelixis Announces Cabozantinib Significantly Improved Progression-Free Survival in COSMIC-311 Phase 3 Pivotal Trial in Patients with Previously Treated Radioiodine-Refractory Differentiated Thyroid Cancer
- Exelixis In-Licenses Aurigene’s Novel CDK7 Inhibitor and Files Investigational New Drug Application for Phase 1 Clinical Trial in Advanced Solid Tumors
- Exelixis In-Licenses Iconic Therapeutics’ Tissue Factor-Targeting Antibody-Drug Conjugate Ahead of Planned Investigational New Drug Application
Add a comment
Comments
0 comments on the analysis EXELIXIS INC. - Daily